2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Golden Biotechnology Corporation

Company Presentations

Wednesday, July 22 Company Presentations 1–Pharma

Golden Biotechnology Corporation

Company Info

Name /Golden Biotechnology Corporation

Address /15F, No. 27- 6, Sec.2, Zhongzheng E. Rd.,Tamsui Dist., New Taipei City 251, Taiwan

Website /www.goldenbiotech.com

Presenter

Name /Dr. Today Su

Title /CEO

Email /today.su@goldenbiotech.com

Telephone /(Work) + 886 2 2808-6006

Fax /+ 886 2 2808-6005

Mobile /+886-922-669-672

Company Type

Pharmaceutical

About the Company

“Breakthroughs for the Ideal Medicine You Desire”

Golden Biotechnology Corporation is a clinical stage biopharmaceutical company focused on discovery and clinical development of innovative therapeutic new drugs (NCE), and dedicated to improving quality of life by developing products that prevent and treat diseases.We also produce evidence-based helth supplement products used in liver protection, immune modulation, prostate health .etc.

Brief Description of main products or services

Golden Biotech discovered from its own screening platforms Antroquinonol® (trade name Hocena®), which has been granted more than 140 patents worldwide for its structure, preparation method and applications in oncology, cardio-metabolic syndromes, autoimmune diseases and neurodegenerative diseases. Since 2013, Antroquinonol® was authorized Phase II clinical trial on NSCLC by US FDA and Taiwan FDA, and entered multiple trials afterwards for various indications. Orphan Drug Designations (ODD) were obtained in treatment of pancreatic cancer (US #14-4608, EU), acute myeloid leukemia (AML) (#15-4763) and hepatocellular carcinoma (#15-4881).

 

The ubiquinone-like structure of Antroquinonol® exhibits a broad spectrum of activities against malignancies in vivo and in vitro, and offers a better solution than the single-action compounds the industry has developed so far. Antroquinonol®’s multiple, simultaneous, and synergistic actions enable positive outcomes. Antroquinonol® can be used as a monotherapy, combination- or adjuvant-therapy to complement other drugs, or as a best supportive care. Demonstrated safety profile and efficacy make Antroquinonol® an ideal asset in treating diseases and improving overall quality of life of patients.

 

Golden Biotech is seeking out-licensing and/or co-development opportunities to further clinical development and commercialization.

Contact Person

Name /Charles Yeh

Email /charlesyeh@goldenbiotech.com

Phone /+ 886 2 2808-6006, +886 9 72626016(Mobile)